MSD applies for injunction against companies infringing ezetimibe patent
MSD applied for an injunction of sales prohibition against 3 companies, such as Daewoong Pharmaceutical, Handok and Alvogen Korea for infringement of the ezetimibe patent.
The 3 companies including Daewoong Pharmaceutical launched hyperlipidemia complexes combining ezetimibe and rosuvastatin on ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
